[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (22,201)

Search Parameters:
Keywords = injectable

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
10 pages, 574 KiB  
Article
Verification of Nasogastric Tube Positioning Using Ultrasound by an Intensive Care Nurse: A Pilot Study
by María Robles-González, Oscar Arrogante, Juan Antonio Sánchez Giralt, Ismael Ortuño-Soriano and Ignacio Zaragoza-García
Healthcare 2024, 12(16), 1618; https://doi.org/10.3390/healthcare12161618 (registering DOI) - 14 Aug 2024
Viewed by 103
Abstract
Placing a nasogastric tube (NGT) is a frequent nursing technique in intensive care units. The gold standard for its correct positioning is the chest X-ray due to its high sensitivity, but it represents a radiation source for critically ill patients. Our study aims [...] Read more.
Placing a nasogastric tube (NGT) is a frequent nursing technique in intensive care units. The gold standard for its correct positioning is the chest X-ray due to its high sensitivity, but it represents a radiation source for critically ill patients. Our study aims to analyze whether the ultrasound performed by an intensive care nurse is a valid method to verify the NGT’s correct positioning and to evaluate the degree of interobserver agreement between this nurse and an intensive care physician in the NGT visualization using ultrasound. Its correct positioning was verified by direct visualization of the tube in the stomach and indirect visualization by injecting fluid and air through the tube (“dynamic fogging” technique). A total of 23 critically ill patients participated in the study. A sensitivity of 35% was achieved using direct visualization, increasing up to 85% using indirect visualization. The degree of interobserver agreement was 0.88. Therefore, the indirect visualization of the NGT by an intensive care nurse using ultrasound could be a valid method to check its positioning. However, the low sensitivity obtained by direct visualization suggests the need for further training of intensive care nurses in ultrasonography. According to the excellent degree of agreement obtained, ultrasound could be performed by both professionals. Full article
(This article belongs to the Section Nursing)
Show Figures

Figure 1

Figure 1
<p>Ultrasound image of a 14-French gauge nasogastric tube placed in the stomach (the red arrow indicates two hyperechogenic parallel lines).</p>
Full article ">
10 pages, 2183 KiB  
Article
Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
by Hsin-Yu Weng, Fang-Ting Chen, Ling-Uei Wang, Tzu-Lun Huang, Wei-Ting Ho, Pei-Yao Chang, Yung-Ray Hsu, Yun-Ju Chen and Jia-Kang Wang
Medicina 2024, 60(8), 1311; https://doi.org/10.3390/medicina60081311 (registering DOI) - 14 Aug 2024
Viewed by 124
Abstract
Background and Objectives: Our study compared the visual and anatomical outcomes of polypoidal choroidal vasculopathy (PCV) patients receiving intravitreal aflibercept (IVA) with or without photodynamic therapy (PDT) over 12 months. Materials and Methods: This retrospective study was performed for 60 eyes [...] Read more.
Background and Objectives: Our study compared the visual and anatomical outcomes of polypoidal choroidal vasculopathy (PCV) patients receiving intravitreal aflibercept (IVA) with or without photodynamic therapy (PDT) over 12 months. Materials and Methods: This retrospective study was performed for 60 eyes from 60 patients with treatment-naïve PCV. Thirty eyes were treated using IVA monotherapy (IVA group), and thirty eyes were treated using a combination of IVA with PDT (IVA/PDT group). The baseline characteristics, treatment outcomes, and retreatment rates were compared between the two groups over a one-year follow-up period. Results: The best-corrected visual acuity (BCVA) was found to have improved significantly in the IVA/PDT group at every 3-month visit. However, no significant BCVA improvement was observed in the IVA group. A significantly lower retreatment rate and higher dry macula rate were found in the IVA/PDT group than that in the IVA group. In the entire population of the study, a better baseline vision and younger age were associated with better final visual outcomes. Retreatment was associated with poor baseline BCVA and IVA monotherapy. Conclusions: The combination of IVA and PDT may offer superior visual improvement and a higher dry macula rate compared to IVA monotherapy in the treatment of PCV patients while requiring fewer retreatments over 12 months. Full article
(This article belongs to the Section Ophthalmology)
Show Figures

Figure 1

Figure 1
<p>Changes in mean best-corrected visual acuity (BCVA) in LogMAR for two groups (* <span class="html-italic">p</span> &lt; 0.05 compared with baseline BCVA).</p>
Full article ">Figure 2
<p>Changes in mean central retinal thickness (CRT) for two groups (* <span class="html-italic">p</span> &lt; 0.05 compared with baseline CRT).</p>
Full article ">Figure 3
<p>Changes in dry macula rate of two groups (* <span class="html-italic">p</span> &lt; 0.05 compared between the two groups).</p>
Full article ">Figure 4
<p>This is a 76-year-old man diagnosed with polypoidal choroidal vasculopathy (PCV) in his right eye. (<b>A</b>–<b>C</b>) are images taken prior to treatment, (<b>D</b>–<b>F</b>) are images captured 3 months after IVA/PDT treatment, and (<b>G</b>) is an image obtained 12 months after IVA/PDT treatment. (<b>A</b>) Fluorescein angiography (FA) shows fluorescein leakages. (<b>B</b>) Indocyanine green angiography (ICGA) shows polypoidal lesions (arrows). (<b>C</b>) Optical coherence tomography (OCT) reveals pigment epithelial detachment (PED), subretinal and intraretinal fluid. (<b>D</b>) FA shows staining without active leakage. (<b>E</b>) ICGA demonstrates complete regression of the polyp. (<b>F</b>,<b>G</b>) OCT reveals no subretinal or intraretinal fluid, although pigment epithelial detachment (PED) persists.</p>
Full article ">
18 pages, 4478 KiB  
Article
Experimental Study on the Spray Characteristics of Diesel and Hydrotreated Vegetable Oil (HVO) Fuels under Different Injection Pressures
by Chang Zhai, Kuichun Li, Pengbo Dong, Yu Jin, Hongliang Luo, Beini Zhou and Yang Liu
Processes 2024, 12(8), 1697; https://doi.org/10.3390/pr12081697 (registering DOI) - 14 Aug 2024
Viewed by 180
Abstract
This investigation employed the diffused back-illumination (DBI) technique to analyze the spray characteristics of hydrotreated vegetable oil (HVO) fuel at three injection pressures and compared them with conventional diesel fuel. The results showed that as the injection pressure increased, the peak injection rates [...] Read more.
This investigation employed the diffused back-illumination (DBI) technique to analyze the spray characteristics of hydrotreated vegetable oil (HVO) fuel at three injection pressures and compared them with conventional diesel fuel. The results showed that as the injection pressure increased, the peak injection rates of both the HVO and diesel increased. At injection pressures above 120 MPa, the injection rates of both fuels were nearly identical, though differences were observed at lower pressures. Increasing the injection pressure reduced the injection delay. The HVO fuel exhibited a shorter spray tip penetration, lower equivalence ratio, larger spray angle, and spray volume, but its spray angle stability was lower than that of diesel. The ambient gas entrainment rate primarily occurred in two stages, significantly influenced by the spray breakup development stage. For diesel sprays, the injection pressure mainly affected the equivalence ratio near the nozzle with minimal downstream impact. Dent’s model provided better predictions of the penetration distance for diesel, while Hiroyasu’s model was more accurate in predicting the penetration distance of the HVO at 120 MPa and 180 MPa. Inagaki’s model performed better in predicting the spray angle for diesel, whereas Hiroyasu’s model was more accurate for the HVO spray angle predictions. Through this research, a better understanding of the spray characteristics of green fuels will be achieved, providing a reference for the design and optimization of new generation engines. Full article
(This article belongs to the Special Issue Clean Combustion and Emission in Vehicle Power System, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Schematic of 10-hole nozzles, reproduced from [<a href="#B20-processes-12-01697" class="html-bibr">20</a>].</p>
Full article ">Figure 2
<p>Experimental setup, reproduced from [<a href="#B20-processes-12-01697" class="html-bibr">20</a>].</p>
Full article ">Figure 3
<p>Injection rate.</p>
Full article ">Figure 4
<p>Diffuse back-illumination images of the spray.</p>
Full article ">Figure 5
<p>Definition of spray properties [<a href="#B26-processes-12-01697" class="html-bibr">26</a>] (Reproduced with permission from author, Fuel, Elsevier, 2021).</p>
Full article ">Figure 6
<p>Spray tip penetration with different conditions.</p>
Full article ">Figure 7
<p>Spray angle with different conditions.</p>
Full article ">Figure 8
<p>Average spray angle with different conditions.</p>
Full article ">Figure 9
<p>Spray area with different conditions.</p>
Full article ">Figure 10
<p>Spray volume calculation method and results [<a href="#B26-processes-12-01697" class="html-bibr">26</a>] (Reproduced with permission from author, Fuel, Elsevier, 2021).</p>
Full article ">Figure 11
<p>Characteristics of entrainment with different conditions.</p>
Full article ">Figure 11 Cont.
<p>Characteristics of entrainment with different conditions.</p>
Full article ">Figure 12
<p>Average equivalence ratio.</p>
Full article ">Figure 13
<p>Comparison of the experimental data of the spray tip penetration with the prediction models.</p>
Full article ">Figure 14
<p>Comparison of the experimental data of the spray angle with the prediction models.</p>
Full article ">
26 pages, 9063 KiB  
Article
Forearm Intravenous Detection and Localization for Autonomous Vein Injection Using Contrast-Limited Adaptive Histogram Equalization Algorithm
by Hany Said, Sherif Mohamed, Omar Shalash, Esraa Khatab, Omar Aman, Ramy Shaaban and Mohamed Hesham
Appl. Sci. 2024, 14(16), 7115; https://doi.org/10.3390/app14167115 (registering DOI) - 13 Aug 2024
Viewed by 264
Abstract
Occasionally intravenous insertion forms a challenge to a number of patients. Inserting an IV needle is a difficult task that requires aot of skill. At the moment, only doctors and medical personnel are allowed to do this because it requires finding the right [...] Read more.
Occasionally intravenous insertion forms a challenge to a number of patients. Inserting an IV needle is a difficult task that requires aot of skill. At the moment, only doctors and medical personnel are allowed to do this because it requires finding the right vein, inserting the needle properly, and carefully injecting fluids or drawing out blood. Even for trained professionals, this can be done incorrectly, which can cause bleeding, infection, or damage to the vein. It is especially difficult to do this on children, elderly people, and people with certain skin conditions. In these cases, the veins are harder to see, so it isessikely to be done correctly the first time and may cause blood clots. In this research, aow-cost embedded system utilizing Near-Infrared (NIR)ight technology is developed, and two novel approaches are proposed to detect and select the best candidate veins. The two approaches utilize multiple computer vision tools and are based on contrast-limited adaptive histogram equalization (CLAHE). The accuracy of the proposed algorithm is 91.3% with an average 1.4 s processing time on Raspberry Pi 4 Model B. Full article
Show Figures

Figure 1

Figure 1
<p>Embedded system units: (<b>a</b>) system hardware diagram; (<b>b</b>) acquisition box; (<b>c</b>) system hardware actual model.</p>
Full article ">Figure 2
<p>Vein extraction module process flow.</p>
Full article ">Figure 3
<p>Stage 1, image preparation: (<b>a</b>) original image; (<b>b</b>) cropped image in RGB color; (<b>c</b>) cropped image in grayscale.</p>
Full article ">Figure 4
<p>Stage 2, image enhancement: (<b>a</b>) CLAHE filter; (<b>b</b>) median filter; (<b>c</b>) Gaussianow-pass filter.</p>
Full article ">Figure 5
<p>Stage 3, vein segmentation: (<b>a</b>) segmentation using adaptive threshold; (<b>b</b>) image complement.</p>
Full article ">Figure 6
<p>Stage 4, fine-tuning segmentation: (<b>a</b>) morphological opening; (<b>b</b>) morphological closing; (<b>c</b>) elliptical mask.</p>
Full article ">Figure 7
<p>Vein selection using Model A.</p>
Full article ">Figure 8
<p>Vein selection using Model B.</p>
Full article ">Figure 9
<p>Stage 5, vein selection using Model A: (<b>a</b>) contour with highest perimeter; (<b>b</b>) vein selection using Model A. The redine and greenine in (<b>a</b>,<b>b</b>) correspond to the vein extraction’s output that is displayed through the segmented and captured images respectively.</p>
Full article ">Figure 10
<p>Stage 5, vein selection using Model B for image with original spatial resolution: (<b>a</b>) highlighting vein for binary image; (<b>b</b>) detected vein in the cropped image. The greenine is the module selection output, and the rest of the image is the retrieved infrared image from the camera.</p>
Full article ">Figure 11
<p>Stage 5 Vein Selection using Model B for image with oneevel downsample: (<b>a</b>) Highlighting Vein for Binary Image; (<b>b</b>) Detected Vein in the Cropped Image.</p>
Full article ">Figure 11 Cont.
<p>Stage 5 Vein Selection using Model B for image with oneevel downsample: (<b>a</b>) Highlighting Vein for Binary Image; (<b>b</b>) Detected Vein in the Cropped Image.</p>
Full article ">Figure 12
<p>Stage 5, vein selection using Model B for image with twoevels downsample: (<b>a</b>) highlighting vein for binary image; (<b>b</b>) detected vein in the cropped image. The redine and greenine in (<b>a</b>,<b>b</b>) correspond to the vein extraction’s output that is displayed through the segmented and captured images respectively.</p>
Full article ">Figure 13
<p>Matching vein selection results for Image 7: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 14
<p>Matching vein selection results for Image 12: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 14 Cont.
<p>Matching vein selection results for Image 12: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 15
<p>Similar vein selection results for Image 16: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 16
<p>Similar vein selection results for Image 22: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 16 Cont.
<p>Similar vein selection results for Image 22: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 17
<p>Multiple correct vein selections for Image 1: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 18
<p>Multiple correct vein selections for Image 15: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 19
<p>Model A correctly identifies vein selection for Image 6: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 20
<p>Model A correctly identifies vein selection for Image 9: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 21
<p>Model B correctly identifies vein selection for Image 3: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 22
<p>False detection for vein selection using Model B for Image 18: (<b>a</b>) original image; (<b>b</b>) models’ output.</p>
Full article ">Figure 23
<p>Showingocalized points of the vein: (<b>a</b>) original image; (<b>b</b>) retrieved points.</p>
Full article ">
14 pages, 723 KiB  
Article
Dynamic Injection and Permutation Coding for Enhanced Data Transmission
by Kehinde Ogunyanda, Opeyemi O. Ogunyanda and Thokozani Shongwe
Entropy 2024, 26(8), 685; https://doi.org/10.3390/e26080685 (registering DOI) - 13 Aug 2024
Viewed by 152
Abstract
In this paper, we propose a novel approach to enhance spectral efficiency in communication systems by dynamically adjusting the mapping between cyclic permutation coding (CPC) and its injected form. By monitoring channel conditions such as interference levels and impulsive noise strength, the system [...] Read more.
In this paper, we propose a novel approach to enhance spectral efficiency in communication systems by dynamically adjusting the mapping between cyclic permutation coding (CPC) and its injected form. By monitoring channel conditions such as interference levels and impulsive noise strength, the system optimises the coding scheme to maximise data transmission reliability and efficiency. The CPC method employed in this work maps information bits onto non-binary symbols in a cyclic manner, aiming to improve the Hamming distance between mapped symbols. To address challenges such as low data rates inherent in permutation coding, injection techniques are introduced by removing δ column(s) from the CPC codebook. Comparative analyses demonstrate that the proposed dynamic adaptation scheme outperforms conventional permutation coding and injection schemes. Additionally, we present a generalised mathematical expression to describe the relationship between the spectral efficiencies of both coding schemes. This dynamic approach ensures efficient and reliable communication in environments with varying levels of interference and impulsive noise, highlighting its potential applicability to systems like power line communications. Full article
(This article belongs to the Special Issue New Advances in Error-Correcting Codes)
Show Figures

Figure 1

Figure 1
<p>Rate gain vs. <span class="html-italic">M</span> at various <math display="inline"><semantics> <mi>δ</mi> </semantics></math> values.</p>
Full article ">Figure 2
<p>Logical topology for dynamic adaptation.</p>
Full article ">Figure 3
<p>Interference level <math display="inline"><semantics> <mi>γ</mi> </semantics></math> vs. BER for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 4
<p><math display="inline"><semantics> <mrow> <msub> <mi>E</mi> <mi>b</mi> </msub> <mo>/</mo> <msub> <mi>N</mi> <mn>0</mn> </msub> </mrow> </semantics></math> vs. BER at <math display="inline"><semantics> <mrow> <mi>γ</mi> <mo>=</mo> <mn>0</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mo>Γ</mo> <mo>→</mo> <mo>∞</mo> </mrow> </semantics></math> for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 5
<p><math display="inline"><semantics> <mrow> <msub> <mi>E</mi> <mi>b</mi> </msub> <mo>/</mo> <msub> <mi>N</mi> <mn>0</mn> </msub> </mrow> </semantics></math> vs. BER at <math display="inline"><semantics> <mrow> <mi>γ</mi> <mo>=</mo> <mn>0.01</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mo>Γ</mo> <mo>=</mo> <mn>0.99</mn> </mrow> </semantics></math> for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 6
<p><math display="inline"><semantics> <mrow> <msub> <mi>E</mi> <mi>b</mi> </msub> <mo>/</mo> <msub> <mi>N</mi> <mn>0</mn> </msub> </mrow> </semantics></math> vs. BER at <math display="inline"><semantics> <mrow> <mi>γ</mi> <mo>=</mo> <mn>1</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mo>Γ</mo> <mo>=</mo> <mn>0.99</mn> </mrow> </semantics></math> for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 7
<p>Interference level <math display="inline"><semantics> <mi>γ</mi> </semantics></math> vs. BER for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>8</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 8
<p><math display="inline"><semantics> <mrow> <msub> <mi>E</mi> <mi>b</mi> </msub> <mo>/</mo> <msub> <mi>N</mi> <mn>0</mn> </msub> </mrow> </semantics></math> vs. BER at <math display="inline"><semantics> <mrow> <mi>γ</mi> <mo>=</mo> <mn>0</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mo>Γ</mo> <mo>→</mo> <mo>∞</mo> </mrow> </semantics></math> for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>8</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 9
<p><math display="inline"><semantics> <mrow> <msub> <mi>E</mi> <mi>b</mi> </msub> <mo>/</mo> <msub> <mi>N</mi> <mn>0</mn> </msub> </mrow> </semantics></math> vs. BER at <math display="inline"><semantics> <mrow> <mi>γ</mi> <mo>=</mo> <mn>0.01</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mo>Γ</mo> <mo>=</mo> <mn>0.99</mn> </mrow> </semantics></math> for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>8</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">Figure 10
<p><math display="inline"><semantics> <mrow> <msub> <mi>E</mi> <mi>b</mi> </msub> <mo>/</mo> <msub> <mi>N</mi> <mn>0</mn> </msub> </mrow> </semantics></math> vs. BER at <math display="inline"><semantics> <mrow> <mi>γ</mi> <mo>=</mo> <mn>1</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mo>Γ</mo> <mo>=</mo> <mn>0.99</mn> </mrow> </semantics></math> for <math display="inline"><semantics> <mrow> <mi>M</mi> <mo>=</mo> <mn>8</mn> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msup> <mi>M</mi> <mo>′</mo> </msup> <mo>=</mo> <mn>3</mn> </mrow> </semantics></math> codebooks.</p>
Full article ">
16 pages, 3558 KiB  
Article
Preparation and Characterization of Responsive Cellulose-Based Gel Microspheres for Enhanced Oil Recovery
by Peng Yin, Fang Shi, Mingjian Luo, Jingchun Wu, Bo Zhao, Chunlong Zhang, Yi Shen and Yanbing Chen
Gels 2024, 10(8), 532; https://doi.org/10.3390/gels10080532 - 13 Aug 2024
Viewed by 227
Abstract
As an important means to enhance oil recovery, ternary composite flooding (ASP flooding for short) technology has achieved remarkable results in Daqing Oilfield. Alkalis, surfactants and polymers are mixed in specific proportions and injected into the reservoir to give full play to the [...] Read more.
As an important means to enhance oil recovery, ternary composite flooding (ASP flooding for short) technology has achieved remarkable results in Daqing Oilfield. Alkalis, surfactants and polymers are mixed in specific proportions and injected into the reservoir to give full play to the synergistic effect of each component, which can effectively enhance the fluidity of crude oil and greatly improve the oil recovery. At present, the technology for further improving oil recovery after ternary composite flooding is not mature and belongs to the stage of technical exploration. The presence of alkaline substances significantly alters the reservoir’s physical properties and causes considerable corrosion to the equipment used in its development. This is detrimental to both the environment and production. Therefore, it is necessary to develop green displacement control agents. In the reservoir environment post-ASP flooding, 2-(methylamino)ethyl methacrylate and glycidyl methacrylate were chosen as monomers to synthesize a polymer responsive to alkali, and then grafted with cellulose nanocrystals to form microspheres of alkali-resistant swelling hydrogel. Cellulose nanocrystals (CNCs) modified with functional groups and other materials were utilized to fabricate hydrogel microspheres. The product’s structure was characterized and validated using Fourier transform infrared spectroscopy and X-ray diffraction. The infrared spectrum revealed characteristic absorption peaks of CNCs at 1165 cm−1, 1577 cm−1, 1746 cm−1, and 3342 cm−1. The diffraction spectrum corroborated the findings of the infrared analysis, indicating that the functional modification occurred on the CNC surface. After evaluating the swelling and erosion resistance of the hydrogel microspheres under various alkaline conditions, the optimal particle size for compatibility with the target reservoir was determined to be 6 μm. The potential of cellulose-based gel microspheres to enhance oil recovery was assessed through the evaluation of Zeta potential and laboratory physical simulations of oil displacement. The study revealed that the absolute value of the Zeta potential for gel microspheres exceeds 30 in an alkaline environment with pH values ranging from 7 to 14, exhibiting a phenomenon where stronger alkalinity correlates with a greater absolute value of Zeta potential. The dispersion stability spans from good to excellent. The laboratory oil displacement simulation experiment was conducted using a cellulose-based gel microsphere system following weak alkali ASP flooding within the pH value range from 7 to 10. The experimental interventions yielded recovery rates of 2.98%, 3.20%, 3.31%, and 3.38%, respectively. The study indicates that cellulose-based gel microspheres exhibit good adaptability in alkaline reservoirs. This research offers a theoretical foundation and experimental approaches to enhance oil recovery techniques post-ASP flooding. Full article
(This article belongs to the Special Issue Polymer Gels for the Oil and Gas Industry)
Show Figures

Figure 1

Figure 1
<p>Graph of infrared spectroscopy characterization.</p>
Full article ">Figure 2
<p>Graph of comparison of diffraction spectra.</p>
Full article ">Figure 3
<p>Particle size distribution of hydrogel microspheres.</p>
Full article ">Figure 4
<p>Curve of the variation law of the expansion rate of hydrogel microspheres of 3 to 6 μm.</p>
Full article ">Figure 5
<p>Curve of the variation law of the expansion rate of the 9 μm hydrogel microspheres.</p>
Full article ">Figure 6
<p>Injection performance curve for hydrogel microspheres with different particle sizes.</p>
Full article ">Figure 7
<p>Measured curve of the variation in Zeta potential with pH value.</p>
Full article ">Figure 8
<p>Dynamic curve of gel microdisplacement (pH value = 7).</p>
Full article ">Figure 9
<p>Dynamic curve of gel microdisplacement (pH value = 8).</p>
Full article ">Figure 10
<p>Dynamic curve of gel microdisplacement (pH value = 9).</p>
Full article ">Figure 11
<p>Dynamic curve of gel microdisplacement (pH value = 10).</p>
Full article ">Figure 12
<p>Flow chart of hydrogel microsphere preparation.</p>
Full article ">
12 pages, 2259 KiB  
Article
Charge Variants Characterization of Co-Formulated Antibodies by Three-Dimensional Liquid Chromatography–Mass Spectrometry
by Xiaoqing Jin, Luna Chen, Jianlin Chu and Bingfang He
Biomolecules 2024, 14(8), 999; https://doi.org/10.3390/biom14080999 (registering DOI) - 13 Aug 2024
Viewed by 126
Abstract
Co-formulated antibodies can bring clinical benefits to patients by combining two or more antibodies in a single dosage form. However, the quality analysis of co-formulated antibodies raises additional challenges, compared to individual antibodies, due to the need for accurate analysis of multiple antibodies [...] Read more.
Co-formulated antibodies can bring clinical benefits to patients by combining two or more antibodies in a single dosage form. However, the quality analysis of co-formulated antibodies raises additional challenges, compared to individual antibodies, due to the need for accurate analysis of multiple antibodies in one solution. It is extremely difficult to effectively separate the charge variants of the two co-formulated antibodies using one ion exchange chromatography (IEC) method because of their similar characteristics. In this study, a novel method was developed for the charge variants characterization of co-formulated antibodies using three-dimensional liquid chromatography–mass spectrometry (3D-LC-MS). Hydrophobic interaction chromatography (HIC) was used as the first dimension to separate and collect the two co-formulated antibodies. The two collections were then injected into the second-dimension IEC separately for charge variants separation and analysis. Subsequently, the separated charge variants underwent on-line desalting in the third-dimension reverse-phase chromatography (RPC) and subsequent mass spectroscopy analysis. The novel method could simultaneously provide a charge variants ratio and post-translational modification (PTM) data for the two co-formulated antibodies. Therefore, it could be used for release testing and stability studies of co-formulated antibodies, making up for the shortcomings of the existing approaches. It was the first time that charge variants of co-formulated antibodies were characterized by the 3D-LC-MS method, to the best of our knowledge. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic diagram of the 3D-LC-MS method for the charge variants characterization of co-formulated antibodies.</p>
Full article ">Figure 2
<p>Chromatography of mAb A and mAb B in the HIC optimization. (<b>A1</b>) mAb A under the conditions of optimization 1; (<b>A2</b>) mAb B under the conditions of optimization 1; (<b>B1</b>) mAb A under the conditions of optimization 2; (<b>B2</b>) mAb B under the conditions of optimization 2; (<b>C1</b>) mAb A under the conditions of optimization 3; and (<b>C2</b>) mAb B under the conditions of optimization 3.</p>
Full article ">Figure 3
<p>Chromatography overlay in optimized HIC. (<b>A</b>) Individual mAb A, individual mAb B, and co-formulated antibodies in optimized HIC; (<b>B</b>) co-formulated antibodies in optimized HIC in triplicate. The difference in the retention time was due to the different columns and HPLCs, but there was no detrimental effect on the resolutions of the mAb A peak and the mAb B peak.</p>
Full article ">Figure 4
<p>Raw MS spectra and deconvoluted MS spectra of charge variants of mAb A in co-formulated antibodies using the 3D-LC-MS method. (<b>A1</b>) Raw MS spectra of acidic peak 1; (<b>A2</b>) deconvoluted MS spectra of acidic peak 1; (<b>B1</b>) raw MS spectra of acidic peak 2; (<b>B2</b>) deconvoluted MS spectra of acidic peak 2; (<b>C1</b>) raw MS spectra of main peak 3; (<b>C2</b>) deconvoluted MS spectra of main peak 3; (<b>D1</b>) raw MS spectra of basic peak 4; (<b>D2</b>) deconvoluted MS spectra of basic peak 4; (<b>E1</b>) raw MS spectra of basic peak 5; and (<b>E2</b>) deconvoluted MS spectra of basic peak 5. There were some species with +98 Da in the deconvoluted MS spectra, which arose from the attachment of phosphoric acid. Phosphoric acid adducts were very common in MS [<a href="#B19-biomolecules-14-00999" class="html-bibr">19</a>] when phosphoric acid was used in the mobile phase, even though the desalting step was utilized before MS.</p>
Full article ">Figure 5
<p>Raw MS spectra and deconvoluted MS spectra of charge variants of mAb B in co-formulated antibodies using the 3D-LC-MS method. (<b>A1</b>) Raw MS spectra of acidic peak 1; (<b>A2</b>) deconvoluted MS spectra of acidic peak 1; (<b>B1</b>) raw MS spectra of acidic peak 2; (<b>B2</b>) deconvoluted MS spectra of acidic peak 2; (<b>C1</b>) raw MS spectra of main peak 3; (<b>C2</b>) deconvoluted MS spectra of main peak 3; (<b>D1</b>) raw MS spectra of basic peak 4; (<b>D2</b>) deconvoluted MS spectra of basic peak 4; (<b>E1</b>) raw MS spectra of basic peak 5; and (<b>E2</b>) deconvoluted MS spectra of basic peak 5. There were some species with +98 Da in the deconvoluted MS spectra, which arose from the attachment of phosphoric acid. Phosphoric acid adducts were very common in MS [<a href="#B19-biomolecules-14-00999" class="html-bibr">19</a>] when phosphoric acid was used in the mobile phase, even though the desalting step was utilized before MS.</p>
Full article ">
11 pages, 11233 KiB  
Article
Enhancing High-Alloy Steel Cutting with Abrasive Water Injection Jet (AWIJ) Technology: An Approach Using the Response Surface Methodology (RSM)
by Andrzej Perec, Elzbieta Kawecka and Frank Pude
Materials 2024, 17(16), 4020; https://doi.org/10.3390/ma17164020 - 13 Aug 2024
Viewed by 252
Abstract
The common machining technologies for difficult-to-machine materials do not remarkably ensure acceptable efficiency and precision in bulk materials cutting. High-energy abrasive water injection jet (AWIJ) treatment can cut diverse materials, even multi-layer composites characterized by divergent properties, accurately cutting complex profiles and carrying [...] Read more.
The common machining technologies for difficult-to-machine materials do not remarkably ensure acceptable efficiency and precision in bulk materials cutting. High-energy abrasive water injection jet (AWIJ) treatment can cut diverse materials, even multi-layer composites characterized by divergent properties, accurately cutting complex profiles and carrying them out in special circumstances, such as underwater locations or explosion hazard areas. This work reports research on the AWIJ machining quality performance of X22CrMoV12-1 high-alloy steel. The response surface method (RSM) was utilized in modeling. The most influencing process control parameters on cut kerf surface roughness—abrasive flow rate, pressure, and traverse speed—were tested. The result is a mathematical model of the process in the form of a three-variable polynomial. The key control parameter affecting the cut slot roughness turned out to be the traverse speed. In contrast, pressure has a less significant effect, and the abrasive mass flow rate has the slightest impact on the cut slot roughness. Under the optimal conditions determined as a result of the tests, the roughness of the intersection surface Sq does not exceed 2.3 μm. Based on the ANOVA, we confirmed that the model fits over 96% appropriately with the research outcomes. This method reduces the computations and sharply determines the optimum set of control parameters. Full article
(This article belongs to the Special Issue Advances in Metal Cutting, Casting, Forming and Heat Treatment)
Show Figures

Figure 1

Figure 1
<p>J80A garnet: (<b>a</b>) grain SEM image, (<b>b</b>) light microscope image, (<b>c</b>) particle distribution.</p>
Full article ">Figure 2
<p>Measurements and observation areas on (<b>a</b>) optical microscope, (<b>b</b>) SEM microscope.</p>
Full article ">Figure 3
<p>Illustration of the <span class="html-italic">Sq</span> surface roughness factor.</p>
Full article ">Figure 4
<p>Impact of control factors on <span class="html-italic">Sq</span> surface roughness: (<b>a</b>) traverse speed 50 mm/min, (<b>b</b>) traverse speed 150 mm/min, (<b>c</b>) traverse speed 250 mm/min, (<b>d</b>) pressure 360 MPa, (<b>e</b>) pressure 380 MPa, (<b>f</b>) pressure 400 MPa, (<b>g</b>) abrasive flow 250 g/min, (<b>h</b>) abrasive flow 350 g/min, (<b>i</b>) abrasive flow 450 g/min.</p>
Full article ">Figure 5
<p>Scattering graph of the modeled and measured <span class="html-italic">Sq</span> surface roughness.</p>
Full article ">Figure 6
<p>Example view of cut surface roughness of high-alloy steel: (<b>a</b>) top area I, (<b>b</b>) middle area II, (<b>c</b>) bottom area III.</p>
Full article ">
14 pages, 970 KiB  
Article
Increased Pan-Type, A1-Type, and A2-Type Astrocyte Activation and Upstream Inflammatory Markers Are Induced by the P2X7 Receptor
by Keith E. Campagno, Puttipong Sripinun, Lily P. See, Jiaqi Li, Wennan Lu, Assraa Hassan Jassim, Néstor Más Gómez and Claire H. Mitchell
Int. J. Mol. Sci. 2024, 25(16), 8784; https://doi.org/10.3390/ijms25168784 (registering DOI) - 13 Aug 2024
Viewed by 295
Abstract
This study asked whether the P2X7 receptor was necessary and sufficient to trigger astrocyte polarization into neuroinflammatory activation states. Intravitreal injection of agonist BzATP increased gene expression of pan-astrocyte activation markers Gfap, Steap4, and Vim and A1-type astrocyte activation markers C3 [...] Read more.
This study asked whether the P2X7 receptor was necessary and sufficient to trigger astrocyte polarization into neuroinflammatory activation states. Intravitreal injection of agonist BzATP increased gene expression of pan-astrocyte activation markers Gfap, Steap4, and Vim and A1-type astrocyte activation markers C3, Serping1, and H2T23, but also the Cd14 and Ptx3 genes usually associated with the A2-type astrocyte activation state and Tnfa, IL1a, and C1qa, assumed to be upstream of astrocyte activation in microglia. Correlation analysis of gene expression suggested the P2X7 receptor induced a mixed A1/A2-astrocyte activation state, although A1-state genes like C3 increased the most. A similar pattern of mixed glial activation genes occurred one day after intraocular pressure (IOP) was elevated in wild-type mice, but not in P2X7-/- mice, suggesting the P2X7 receptor is necessary for the glial activation that accompanies IOP elevation. In summary, this study suggests stimulation of the P2X7R is necessary and sufficient to trigger the astrocyte activation in the retina following IOP elevation, with a rise in markers for pan-, A1-, and A2-type astrocyte activation. The P2X7 receptor is expressed on microglia, optic nerve head astrocytes, and retinal ganglion cells (RGCs) in the retina, and can be stimulated by the mechanosensitive release of ATP that accompanies IOP elevation. Whether the P2X7 receptor connects this mechanosensitive ATP release to microglial and astrocyte polarization in glaucoma remains to be determined. Full article
Show Figures

Figure 1

Figure 1
<p>P2X7 agonist BzATP upregulates mixed astrocyte activation markers. Expression of mRNA associated with astrocyte activation states in C57Bl/6J mouse retinas extracted 24 h after intravitreal injection of BzATP (Bz; 250 µM) or saline controls (C). (<b>A</b>) Expression of mRNA for pan-astrocyte activation markers <span class="html-italic">Gfap</span>, <span class="html-italic">Steap4</span>, <span class="html-italic">Vim</span>, <span class="html-italic">Aspg</span>, and <span class="html-italic">SerpinA3N</span> was increased. Throughout the Figure, data were analyzed with a one-way ANOVA with the Šidák multiple comparisons test; * = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001, and ns = not significant; <span class="html-italic">n</span> = 7 pairs. Throughout the manuscript, mRNA expression is expressed as ΔΔCT and normalized to the mean value for control eyes. Box and whisker plots were generated based on Tukey analysis, where the box indicates median ± 25th and 75th percentile, and dots show outliers. (<b>B</b>) BzATP injection also increased the expression of genes associated with the A1 activation state <span class="html-italic">C3</span>, <span class="html-italic">Serping1</span>, <span class="html-italic">H2T23</span>, and <span class="html-italic">H2D1</span>. (<b>C</b>) The rise in genes associated with the A2 activation state <span class="html-italic">Ptx3</span> and <span class="html-italic">Cd14</span> was significant but small.</p>
Full article ">Figure 2
<p>Correlation of gene changes induced by BzATP. Expression of mRNA message in C57Bl/6J mouse retinas extracted 24 h after intravitreal injection of BzATP (Bz, 250 µM) or saline controls (C). (<b>A</b>) Expression of mRNA for <span class="html-italic">Tnfa</span>, <span class="html-italic">Il1a</span>, and <span class="html-italic">C1qa</span> was increased in eyes injected with BzATP as compared to the contralateral eyes injected with equal volumes of saline. One-way ANOVA with Šidák multiple comparisons test, <span class="html-italic">n</span> = 7 pairs; * = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01. (<b>B</b>) Spearman’s correlation between changes in all genes induced by injection of BzATP as compared to levels in the contralateral control retinas. Blue squares indicate a positive correlation and red a negative correlation, with the intensity of color an index of the correlation magnitude. Genes named in black are associated with microglia, green with pan-, red with A1-, and blue with A2-associated activation markers. Correlations with <span class="html-italic">p</span> &lt; 0.05 are marked with a thick cube.</p>
Full article ">Figure 3
<p>A rise in mixed-astrocyte activation markers accompanied IOP elevation in C57Bl/6J mice. (<b>A</b>) Transient elevation of IOP in C57Bl6/J mice (IOP) increased expression of mRNA for genes associated with pan-astrocyte activation, <span class="html-italic">Gfap, Steap4</span>, and <span class="html-italic">Vim</span>, as compared to the unpressurized contralateral control eye (C). mRNA for genes associated with A1-astrocyte activation, <span class="html-italic">C3<sup>+</sup>, Serping1<sup>+</sup></span>, and <span class="html-italic">H2T23</span>, (<b>B</b>) and with the A2-astrocyte activation state, <span class="html-italic">Ptx3, Cd14</span>, and <span class="html-italic">Clcf1</span>, (<b>C</b>) were also increased by IOP elevation. One-way ANOVA with Šidák multiple comparisons test, <span class="html-italic">n</span> = 7 pairs; * = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001, **** = <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>P2X7R is required for the rise in many glial activation markers after IOP elevation. (<b>A</b>) Expression of <span class="html-italic">Tnfa</span> and <span class="html-italic">Il1a</span> increased in retinas from C57Bl/6J mice (C57) but not in P2X7<sup>-/-</sup> mice exposed to a transient IOP elevation (IOP; red for C57, blue for P2X7<sup>-/-</sup> mice). Expression normalized to normotensive control eye. (<b>B</b>) IOP elevation increased <span class="html-italic">Gfap, C3</span>, and <span class="html-italic">Ptx3</span> expression in retinas from C57Bl/6J mice, but not in P2X7<sup>-/-</sup> mice. One-way ANOVA with Šidák multiple comparisons test, <span class="html-italic">n</span> = 6 pairs. * = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001, **** = <span class="html-italic">p</span> &lt; 0.0001, ns = not significant. (<b>C</b>) Spearman’s correlation analysis calculated for changes in mean expression of <span class="html-italic">Tnfa, Il1a, C1qa, Gfap, Steap, Vim, C3, Serping1 H2T23, Ptx3, Cd14,</span> and <span class="html-italic">Clcf1</span> following BzATP injection; transient IOP elevation in C57Bl/6J mice (IOP C57) or P2X7<sup>-/-</sup> mice (IOP P2X7KO). The Spearman’s coefficient is given in boxes; darker blue indicates a closer correlation. Data indicate that the patterns of gene expression changes with BzATP and IOP elevation in C57 mice were closely correlated with each other (<span class="html-italic">p</span> = 0.00015), but not with changes in P2X7<sup>-/-</sup> mice following IOP elevation. The correlation was based on the mean values for each gene from 7, 6, and 6 mice for BzATP, IOP C57, and IOP P2X7KO conditions, respectively, as compared to the contralateral control retinas.</p>
Full article ">
23 pages, 1237 KiB  
Review
Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies
by Hyun Jee Kim and Yeong Ho Kim
Int. J. Mol. Sci. 2024, 25(16), 8776; https://doi.org/10.3390/ijms25168776 (registering DOI) - 12 Aug 2024
Viewed by 295
Abstract
Keloid scars, characterized by abnormal fibroproliferation and excessive extracellular matrix (ECM) production that extends beyond the original wound, often cause pruritus, pain, and hyperpigmentation, significantly impacting the quality of life. Keloid pathogenesis is multifactorial, involving genetic predisposition, immune response dysregulation, and aberrant wound-healing [...] Read more.
Keloid scars, characterized by abnormal fibroproliferation and excessive extracellular matrix (ECM) production that extends beyond the original wound, often cause pruritus, pain, and hyperpigmentation, significantly impacting the quality of life. Keloid pathogenesis is multifactorial, involving genetic predisposition, immune response dysregulation, and aberrant wound-healing processes. Central molecular pathways such as TGF-β/Smad and JAK/STAT are important in keloid formation by sustaining fibroblast activation and ECM deposition. Conventional treatments, including surgical excision, radiation, laser therapies, and intralesional injections, yield variable success but are limited by high recurrence rates and potential adverse effects. Emerging therapies targeting specific immune pathways, small molecule inhibitors, RNA interference, and mesenchymal stem cells show promise in disrupting the underlying mechanisms of keloid pathogenesis, potentially offering more effective and lasting treatment outcomes. Despite advancements, further research is essential to fully elucidate the precise mechanisms of keloid formation and to develop targeted therapies. Ongoing clinical trials and research efforts are vital for translating these scientific insights into practical treatments that can markedly enhance the quality of life for individuals affected by keloid scars. Full article
Show Figures

Figure 1

Figure 1
<p>Keloid pathogenesis.</p>
Full article ">
14 pages, 5113 KiB  
Article
Extracellular Vesicle Transplantation Is Beneficial for Acute Kidney Injury
by Amankeldi A. Salybekov, Shigeaki Okamura, Takayasu Ohtake, Sumi Hidaka, Takayuki Asahara and Shuzo Kobayashi
Cells 2024, 13(16), 1335; https://doi.org/10.3390/cells13161335 - 12 Aug 2024
Viewed by 282
Abstract
Under vasculogenic conditioning, certain pro-inflammatory subsets within peripheral blood mononuclear cells (PBMCs) undergo phenotypic transformation into pro-regenerative types, such as vasculogenic endothelial progenitor cells, M2 macrophages, and regulatory T cells. These transformed cells are collectively termed regeneration-associated cells (RACs). In this study, we [...] Read more.
Under vasculogenic conditioning, certain pro-inflammatory subsets within peripheral blood mononuclear cells (PBMCs) undergo phenotypic transformation into pro-regenerative types, such as vasculogenic endothelial progenitor cells, M2 macrophages, and regulatory T cells. These transformed cells are collectively termed regeneration-associated cells (RACs). In this study, we aimed to investigate the therapeutic efficacy of RAC-derived extracellular vesicles (RACev) compared with a vehicle-treated group in the context of renal ischemia-reperfusion injury (R-IRI). Human PBMCs were cultured with defined growth factor cocktails for seven days to harvest RACs. EV quantity and size were characterized by nanoparticle tracking analysis. Notably, the systemic injection of RACev significantly decreased serum creatinine and blood urine nitrogen at day three compared to the control group. Histologically, the treatment group showed less fibrosis in the cortex and medullary areas (p < 0.04 and p < 0.01) compared to the control group. The CD31 staining confirmed enhanced capillary densities in the treatment group compared to the control group (p < 0.003). These beneficial effects were accompanied by angiogenesis, anti-fibrosis, anti-inflammation, and anti-apoptosis RACev miR delivery to ischemic injury to control inflammatory, endothelial mesenchymal transition, and hypoxia pathways. In vivo bioluminescence analysis demonstrated a preferential accumulation of RACev in the IR-injured kidney. The systemic transplantation of RACev beneficially restored kidney function by protecting from tissue fibrosis and through anti-inflammation, angiogenesis, and anti-apoptosis miR delivery to the ischemic tissue. Full article
(This article belongs to the Special Issue Extracellular Vesicles in Tissue Repair and Regeneration)
Show Figures

Figure 1

Figure 1
<p><b>Characterization of RACs.</b> (<b>A</b>) Total stem and progenitor levels increased after vasculogeneic conditioning. (<b>B</b>) The EPCs were quantitatively and (<b>C</b>,<b>D</b>) qualitatively enhanced in post-vasculogenic culture (the majority by definitive EPC expansion). (<b>E</b>,<b>F</b>) Vasculogenic conditioning dramatically accelerated M1 macrophage phenotype conversion to regenerative macrophage type 2 (<b>G</b>). The level of regulatory T cells. * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001 vs. the control group; Statistical significance was determined using a Mann–Whitney test. n = 10 per group. The results are presented as mean ± SEM. * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 2
<p><b>Characterization of RAC-derived extracellular vesicles.</b> (<b>A</b>) EV-specific anti-CD63 and anti-CD9 biomarker expression in RACev. (<b>B</b>) Representative transmission-electron microscopy figures showed the lipid bilayer structure in RACev. (<b>C</b>) (<b>a</b>) Quantification of one million RAC-derived EVs, (<b>b</b>) average size, and (<b>c</b>) protein amount.</p>
Full article ">Figure 3
<p><b>RACev transplantation restored kidney function.</b> (<b>A</b>) Serum creatinine level at day three significantly decreased in RACev vs. control. (<b>B</b>) Similarly, serum BUN level was dramatically diminished in the RACev transplanted group compared to the Control group. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; ns is not significant vs. the control group; statistical significance was determined using a 2-way ANOVA followed by Tukey’s multiple comparison test. The results are presented as mean ± SEM.</p>
Full article ">Figure 4
<p><b>RACev transplantation preserved renal interstitial fibrosis.</b> (<b>A</b>) Representative Masson trichrome staining depicts reduced or preserved fibrosis area in RACev-transplanted group in comparison to control groups. (<b>B</b>) Fibrosis area quantification in cortex area and (<b>C</b>) medullary area. (<b>D</b>) Anti-fibrosis miRs were significantly upregulated in RACev. (<b>E</b>) Fibrosis-related genes markedly upregulated RACev vs. control four days after the onset of R-IRI. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; ns is not significant vs. the control group. Transcriptome analysis at day four after the onset of AKI demonstrated fibrosis-related gene upregulation in control group vs. RACev. Statistical significance was determined using a one-way ANOVA followed by Dunn’s multiple comparison test. The results are presented as mean ± SEM (n = 8–10 per group).</p>
Full article ">Figure 5
<p><b>Regulation of inflammatory and apoptosis pathways.</b> (<b>A</b>) Gene co-expression network analysis of control group revealed (<b>B</b>) inflammation, EMT, and hypoxia pathway upregulation. (<b>C</b>) RACev-transplanted group demonstrated regeneration-associated pathway upregulation. (<b>D</b>) Anti-inflammatory miRs are abundantly expressed in RACev. (<b>E</b>) Anti-apoptotic and proliferation-associated miR expression in RACev. Differentially expressed miRs were determined using a threshold of absolute values of fold change ≥ 2.</p>
Full article ">Figure 6
<p><b>Enhanced angiogenesis in infarcted tissues.</b> (<b>A</b>) Microvascular density was enhanced in ischemic injured kidney tissue in the RACev-transplanted group. (<b>B</b>) CD31 positive capillary count at day four and (<b>C</b>) day 28 after onset of R-IRI. (<b>D</b>) Angiogenic miRs, also known as angiomiRs, are markedly expressed in RACev. (<b>E</b>) Angiogenesis-related gene expression of RACev vs. control groups’ kidney tissues. ** <span class="html-italic">p</span> &lt; 0.01; ns is not significant vs. control group. Statistical significance was determined using one-way ANOVA with Dunn’s multiple comparisons test. Results are presented as the mean ± SEM (n = 8–10 per group). Differentially expressed miRs were determined using a threshold of absolute values of fold change ≥ 2.</p>
Full article ">Figure 7
<p><b>Selective accumulation of RACev.</b> (<b>A</b>) Schematic design of an in vivo study. (<b>B</b>) Systemic transplantation of labeled RACev preferentially accumulated into the ischemia-injured kidneys. (<b>C</b>,<b>D</b>) Transcriptome cell annotation and mapping showed possible RACev accumulation in the kidney.</p>
Full article ">
13 pages, 3371 KiB  
Article
Safflower Yellow Injection Alleviates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative and Endoplasmic Reticulum Stress
by Wulin Liang, Mingqian Zhang, Jiahui Gao, Rikang Huang, Lu Cheng, Liyuan Zhang, Zhishan Huang, Zhanhong Jia and Shuofeng Zhang
Pharmaceuticals 2024, 17(8), 1058; https://doi.org/10.3390/ph17081058 - 12 Aug 2024
Viewed by 240
Abstract
Safflower yellow is an extract of the famous Chinese medicine Carthamus tinctorious L, and safflower yellow injection (SYI) is widely used clinically to treat angina pectoris. However, there are few studies on the anti-myocardial ischemia/reperfusion (I/R) injury effect of SYI, and its mechanisms [...] Read more.
Safflower yellow is an extract of the famous Chinese medicine Carthamus tinctorious L, and safflower yellow injection (SYI) is widely used clinically to treat angina pectoris. However, there are few studies on the anti-myocardial ischemia/reperfusion (I/R) injury effect of SYI, and its mechanisms are unclear. In the present study, we aimed to investigate the protective effect of SYI on myocardial I/R injury and explore its underlying mechanisms. Male Sprague Dawley rats were randomly divided into a control group, sham group, model group, and SYI group (20 mg/kg, femoral vein injection 1 h before modeling). The left anterior descending coronary artery was ligated to establish a myocardial I/R model. H9c2 cells were exposed to oxygen–glucose deprivation/reoxygenation (OGD/R) after incubation with 80 μg/mL SYI for 24 h. In vivo, TsTC, HE, and TUNEL staining were performed to evaluate myocardial injury and apoptosis. A kit was used to detect superoxide dismutase (SOD) and malondialdehyde (MDA) to assess oxidative stress. In vitro, flow cytometry was used to detect the reactive oxygen species (ROS) content and apoptosis rate. Protein levels were determined via Western blotting. Pretreatment with SYI significantly reduced infarct size and pathological damage in rat hearts and suppressed cardiomyocyte apoptosis in vivo and in vitro. In addition, SYI inhibited oxidative stress by increasing SOD activity and decreasing MDA content and ROS production. Myocardial I/R and OGD/R activate endoplasmic reticulum (ER) stress, as evidenced by increased expression of activating transcription factor 6 (ATF6), glucose-regulated protein 78 (GRP78), cysteinyl aspartate-specific proteinase caspase-12, and C/EBP-homologous protein (CHOP), which were all inhibited by SYI. SYI ameliorated myocardial I/R injury by attenuating apoptosis, oxidative damage, and ER stress, which revealed new mechanistic insights into its application. Full article
(This article belongs to the Section Pharmacology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>SYI reduced myocardial I/R injury in rats. (<b>A</b>) Representative photographs of TTC-stained heart slices. (<b>B</b>) Quantitative analysis of the infarct area (<span class="html-italic">n</span> = 6). (<b>C</b>) LDH activity in serum (<span class="html-italic">n</span> = 6). (<b>D</b>) HE staining shows pathological changes in the myocardium (200× magnification; scale bar is 100 μm). <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the sham group. ** <span class="html-italic">p</span> &lt; 0.01 and *** <span class="html-italic">p</span> &lt; 0.001 compared with the model group.</p>
Full article ">Figure 2
<p>SYI attenuated I/R-induced myocardial apoptosis in rats. (<b>A</b>) Representative TUNEL staining (400× magnification; scale bar is 20 μm). (<b>B</b>) Quantitative analysis of apoptosis (<span class="html-italic">n</span> = 3). (<b>C</b>) The expression levels of Bax and Bcl−2 were analyzed via Western blotting. (<b>D</b>,<b>E</b>) The relative protein expression of Bax and Bcl−2 (<span class="html-italic">n</span> = 3). <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the sham group. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 compared with the model group.</p>
Full article ">Figure 3
<p>SYI attenuated I/R-induced oxidative and ER stress in rat hearts. (<b>A</b>,<b>B</b>) The SOD activity and MDA content in the myocardium (<span class="html-italic">n</span> = 6). (<b>C</b>) The expression levels of ER stress-related proteins (ATF6, GRP78, caspase-12, and CHOP) were analyzed via Western blotting. (<b>D</b>–<b>G</b>) The relative protein expression of ATF6, GRP78, caspase-12, and CHOP (<span class="html-italic">n</span> = 3). <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the sham group. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 compared with the model group.</p>
Full article ">Figure 4
<p>SYI reduced OGD/R-induced injury in H9c2 cells. (<b>A</b>) Cell viability of H9c2 cells incubated with different concentrations of SYI for 24 h. (<b>B</b>) Effects of SYI on cell viability after OGD/R (<span class="html-italic">n</span> = 6). (<b>C</b>) Effects of SYI on OGD/R-induced LDH leakage (<span class="html-italic">n</span> = 3). <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the sham group. * <span class="html-italic">p</span> &lt; 0.05 and *** <span class="html-italic">p</span> &lt; 0.01 compared with the model group.</p>
Full article ">Figure 5
<p>SYI reduced OGD/R-induced apoptosis in H9c2 cells. (<b>A</b>) Hoechst 33342 staining showing the anti-apoptotic potential of SYI. (<b>B</b>) Apoptosis in H9c2 cells was analyzed via flow cytometry. (<b>C</b>) Quantitative analysis of the apoptotic rate (<span class="html-italic">n</span> = 3). (<b>D</b>) Caspase-3 activity (<span class="html-italic">n</span> = 3). (<b>E</b>) The expression levels of Bax and Bcl-2 were analyzed via Western blotting. (<b>F</b>,<b>G</b>) The relative protein expression of Bax and Bcl-2 (<span class="html-italic">n</span> = 3). <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the control group. * <span class="html-italic">p</span> &lt; 0.05 and *** <span class="html-italic">p</span> &lt; 0.001 compared with the model group.</p>
Full article ">Figure 6
<p>SYI attenuated OGD/R-induced oxidative and ER stress in H9c2 cells. (<b>A</b>) The ROS expression level was observed. (<b>B</b>) Quantitative analysis of ROS fluorescence intensity. (<b>C</b>,<b>D</b>) SOD activity and MDA contents in cells (<span class="html-italic">n</span> = 3). (<b>E</b>) The level of ER stress was assessed. (<b>F</b>) Quantitative analysis of ER-Tracker Red staining (<span class="html-italic">n</span> = 3). (<b>G</b>) The expression levels of ER stress-related proteins (ATF6, GRP78, caspase-12, and CHOP) were analyzed via Western blotting. (<b>H</b>–<b>K</b>) The relative protein expression of ATF6, GRP78, caspase-12, and CHOP (<span class="html-italic">n</span> = 3). <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the sham group. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 compared with the model group.</p>
Full article ">
18 pages, 2719 KiB  
Article
A Buffered Local Anesthetic Without Epinephrine: Development, Characterization, and In Vivo Efficacy and Toxicity Analysis
by Daniel Uzbelger Feldman, Billy B. Laun, Chirag Patel, Sonal V. Pande and Sai H. S. Boddu
Pharmaceutics 2024, 16(8), 1058; https://doi.org/10.3390/pharmaceutics16081058 - 12 Aug 2024
Viewed by 584
Abstract
Lidocaine hydrochloride (HCl) 2% with 1:100,000 epinephrine (LW/E) is widely used to prevent pain during dental procedures and has been associated with injection sting, jittering effects, slow onset, and a bitter aftertaste. Since LW/E’s introduction in 1948, no significant modifications have been proposed. [...] Read more.
Lidocaine hydrochloride (HCl) 2% with 1:100,000 epinephrine (LW/E) is widely used to prevent pain during dental procedures and has been associated with injection sting, jittering effects, slow onset, and a bitter aftertaste. Since LW/E’s introduction in 1948, no significant modifications have been proposed. This study aims to design and characterize an improved dental lidocaine HCl injectable formulation without epinephrine (LW/O/E) via buffers, sweeteners, and amino acids. LW/O/E injections were prepared with pH and osmolality values of 6.5–7.0 and 590–610 mOsm/kg. Using the electronic tongue (ETongue), the LW/O/E injectable formulations were characterized for viscosity, injectability, and taste analysis. The results were compared with the LW/E control. In vivo efficacy and anesthetic duration of the samples were measured through radiant heat tail-flick latency (RHTFL) and hot plate (HP) tests and local toxicity was assessed after a single intra-oral injection in Sprague Dawley rats (SDR). The viscosity and injectability values of the LW/O/E samples were found to be comparable to the LW/E injection. ETongue taste analysis showed an improvement in bitterness reduction of the LW/O/E samples compared to the LW/E formulation. Toxicity studies of samples in SDR showed minor and transient signs of erythema/eschar and edema. Anesthetic duration via RHTFL and HP paw withdrawal latency time in SDR were found to be comparable for the LW/O/E Sample 3A and the LW/E injection (p < 0.05). In conclusion, the buffered, higher osmolality and reduced bitterness developed LW/O/E formulation (Sample 3A) could be considered a promising alternative to the LW/E formulation for dental use. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Samples stored at 40 °C without light showed discoloration after 4 months.</p>
Full article ">Figure 2
<p>Taste map based on principal component analysis (PCA) with AHS, PKS, ANS, and SCS sensors. S1: water, S2: 2% lidocaine HCl with 1:100,000 epinephrine (LW/E), S3A: Sample 3A, S3B: Sample 3B, S3C: Sample 3C.</p>
Full article ">Figure 3
<p>Percent bitterness prediction. S1: control water, S2: 2% lidocaine HCl with 1:100,000 epinephrine (LW/E), S3A: Sample 3A, S3B: Sample 3B, S3C: Sample 3C.</p>
Full article ">Figure 4
<p>Histological evaluation of hematoxylin and eosin staining in the oral mucosa of rats injected with various formulations (<b>A</b>) 0.9% Saline solution; (<b>B</b>) Commercial 2% lidocaine HCl with 1:100,000 epinephrine; (<b>C</b>) Dextrose 10% <span class="html-italic">w</span>/<span class="html-italic">v</span> Solution (505 mOsm/L); (<b>D</b>) Dextrose 5% and Sodium Chloride 0.45% Injection (406 mOsm/L); (<b>E</b>) Sample 3A; (<b>F</b>) Sample 3B; (<b>G</b>) Sample 3C. Oral mucosa tissue sections of each mouse were stained with HE at 6, 24, and 96 h of injection in SD rats. Infiltration of leucocytes is indicated by black arrows (<b>C</b>)—6 h, (<b>E</b>)—6 h, (F)—6 h, and (<b>G</b>)—6 h. Scale bar in each image = 50.</p>
Full article ">Figure 5
<p>Paw withdrawal latency time in Sprague Dawley rats. “*”, “#”, and “¤” indicate statistically significant differences between the marketed 2% lidocaine HCl with 1:100,000 epinephrine and samples 3A, 3B, and 3C at the respective time points. Values are shown as mean of <span class="html-italic">n</span> = 6 samples. # <span class="html-italic">p</span> &lt; 0.01 moderate difference; ## <span class="html-italic">p</span> &lt; 0.01 strong difference; ¤¤ <span class="html-italic">p</span> &lt; 0.01 strong difference; *** <span class="html-italic">p</span> &lt; 0.001 very strong difference; ### <span class="html-italic">p</span> &lt; 0.001 very strong difference.</p>
Full article ">Figure 6
<p>Radiant heat tail-flick latency time in Sprague Dawley rats. “*”, “#”, and “¤” indicate statistically significant differences between the marketed 2% lidocaine HCl with 1:100,000 epinephrine and samples 3A, 3B, and 3C at the respective time points. Values are shown as mean of <span class="html-italic">n</span> = 6 samples. # <span class="html-italic">p</span> &lt; 0.01 moderate difference; * <span class="html-italic">p</span> &lt; 0.01 moderate difference; ¤ <span class="html-italic">p</span> &lt; 0.01 moderate difference; ** <span class="html-italic">p</span> &lt; 0.01 strong difference; ¤¤ <span class="html-italic">p</span> &lt; 0.01 strong difference; ## <span class="html-italic">p</span> &lt; 0.01 strong difference; ¤¤¤ <span class="html-italic">p</span> &lt; 0.001 very strong difference.</p>
Full article ">
8 pages, 5221 KiB  
Article
High-Energy Injection-Seeded Single-Frequency Er:YAG Laser at 1645 nm Pumped by a 1532 nm Fiber Laser
by Jiaze Wu, Youlun Ju, Jiawei Fan, Yiming Zhao, Kun Yang, Lijie Geng, Yuanxue Cai, Lei Song, Yaming Zhuang, Shuyun Wu and Xiaoming Duan
Photonics 2024, 11(8), 752; https://doi.org/10.3390/photonics11080752 - 12 Aug 2024
Viewed by 218
Abstract
A single-frequency, Q-switched Er:YAG laser, pumped by a 1532 nm fiber laser, has been demonstrated. At the pulse repetition frequency (PRF) of 200 Hz, the maximum single-frequency laser of 5.5 mJ is attained, and, correspondingly, the pulse width is 212 ns. Using the [...] Read more.
A single-frequency, Q-switched Er:YAG laser, pumped by a 1532 nm fiber laser, has been demonstrated. At the pulse repetition frequency (PRF) of 200 Hz, the maximum single-frequency laser of 5.5 mJ is attained, and, correspondingly, the pulse width is 212 ns. Using the heterodyne technique, the single-frequency laser spectrum’s full width at half maximum is determined to be 2.73 MHz. The experimental results show that the single-frequency laser has excellent beam quality factors (M2) of 1.18 and 1.21. Full article
(This article belongs to the Special Issue Single Frequency Fiber Lasers and Their Applications)
Show Figures

Figure 1

Figure 1
<p>Experimental setup of the seed-injection, single-frequency pulsed Er:YAG laser, pumped by the 1532 nm fiber laser. AOM/Q: acousto-optic modulator; PD1, PD2: photodiodes; Iso: isolator; OC: output coupler; PBS: polarized beam splitter; M: mirror; f: lens; PZT: piezoelectric transducer.</p>
Full article ">Figure 2
<p>Output characteristic of NPRO laser. (<b>a</b>) F-P longitudinal spectrum. (<b>b</b>) Output wavelength. (<b>c</b>) M<sup>2</sup> factor.</p>
Full article ">Figure 3
<p>(<b>a</b>) Output energy and pulse width of the single-frequency Er:YAG laser versus the incident pump power at 200 Hz. (<b>b</b>) Comparisons of the build-up time with and without injection-seeding at 200 Hz.</p>
Full article ">Figure 4
<p>Energy fluctuation of the single-frequency Er:YAG laser at a PRF of 200 Hz.</p>
Full article ">Figure 5
<p>(<b>a</b>) Beating signal of the single-frequency pulse laser and the reference light. (<b>b</b>) FFT spectrum of heterodyne beating signal between the seed laser and the slave laser.</p>
Full article ">Figure 6
<p>Beam quality of the Er:YAG single-frequency pulsed laser.</p>
Full article ">
10 pages, 237 KiB  
Article
STABILITY (Symptomatic Review during Biologic Therapy) of Inflammatory Bowel Disease Patients Receiving Infusion Therapy Improves Clinical Outcomes
by Kelli Morgan, James Morris, Qiang Cai, Phillip Kilgore, Urska Cvek, Marjan Trutschl, Katelynn T. Lofton, Meher Sindhoora Mavuram, Prerana Ramesh, Nhi Dao, Ahmed Alhaque and Jonathan Steven Alexander
Pathophysiology 2024, 31(3), 398-407; https://doi.org/10.3390/pathophysiology31030030 (registering DOI) - 12 Aug 2024
Viewed by 170
Abstract
Several studies have correlate improved patient outcomes with increased physician–patient contacts, particularly in chronic diseases. Extending this approach to inflammatory bowel disease (IBD) care presents a promising means of improving outcomes. At LSU Health Shreveport (LSUHS), a new approach called “STABILITY” (Symptomatic Review [...] Read more.
Several studies have correlate improved patient outcomes with increased physician–patient contacts, particularly in chronic diseases. Extending this approach to inflammatory bowel disease (IBD) care presents a promising means of improving outcomes. At LSU Health Shreveport (LSUHS), a new approach called “STABILITY” (Symptomatic Review during Biologic Therapy) was implemented during infusion therapy visits for IBD patients. These brief 15 min physician–patient interviews aimed to discuss the patients’ current IBD-related symptoms and evaluate the need for any changes in their treatment plan. Our goal was to remove a care gap and prevent intensifying symptoms created by missed appointments and loss of contact. To analyze the effectiveness of the STABILITY approach, a retrospective chart review was conducted on 111 IBD patients (18 with ulcerative colitis, 93 with Crohn’s disease) seen at LSUHS between 2011 and 2022. Since March 2019, STABILITY has been mandatory for all infusion therapy visits. The data collected included patients’ demographics, lab levels for biomarkers (fecal calprotectin, C-reactive protein, and erythrocyte sedimentation rates), hospitalizations, medication changes, and diagnosis dates before and after the implementation of STABILITY. Additionally, voluntary, anonymous infusion patient satisfaction surveys post-STABILITY were used to gather patient responses. In males with IBD, disease severity and hospitalizations were reduced significantly (p = 0.004 and 0.0234, respectively). In females with IBD, disease severity and hospitalizations were also reduced significantly (p = 0.0001 and 0.0072, respectively). In patients with UC and CD, there were significant improvements in disease severity (p = 0.043 and p = 0.0001, respectively), and CD hospitalizations were also improved (p = 0.0013). In males and females with UC, disease severity was marginally and significantly reduced (p = 0.0781 and p = 0.0379, respectively). In males and females with CD, disease severity was significantly reduced (p = 0.0161 and 0.0003, respectively), and CD male and female hospitalizations were also reduced significantly (p = 0.0436 and 0.013). Analyzing of survey responses, we found that the most patients reported improved IBD symptoms (56%), gained understanding of their condition (84%) and were in favor of continuing STABILITY consultations during infusion therapy (93%). To further investigate the impact of STABILITY, we conducted a comparative analysis between IBD patients undergoing STABILITY infusion therapy and LSUHS patients solely on self-injectable biologics. Our paired data analysis showed significant improvements in disease severity in female IBD patients (1.69 ± 0.13 vs. 1.41 ± 0.12, p = 0.0001) and male IBD patients (1.58 ± 0.16 vs. 1.2 ± 0.135, p = 0.004), in UC patients (1.833 ± 0.4.2 vs. 1.444, p = 0.043), in all CD patients (1.59 ± 0.11 vs. 1.29 ± 0.01, p = 0.0001), in male CD patients (1.52 ± 0.167 vs. 1.15 ± 0.15, p = 0.016), in female CD patients (1.66 ± 0.15 vs. 1.4 ± 0.13, p = 0.0003), in female UC patients (1.82 ± 0.32 vs. 1.45 ± 0.31, p = 0.0379), and marginally in male UC patients (p = 0.0781). Similarly, hospitalizations were significantly reduced in CD patients considered in aggregate (0.21 ± 0.04 vs. 0.11 ± 0.03, p = 0.0013), in male IBD patients (0.175 ± 0.06 vs. 0.05 ± 0.035, p = 0.024), in female IBD patients (0.21 ± 0.05 vs. 0.11 ± 0.04, p = 0.0072), in male CD patients (0.18 ± 0.07 vs. 0.06 ± 0.042, p = 0.0436), and in females with CD (0.23 ± 0.06 vs. 0.13 ± 0.04, p = 0.013). Although average values for fecal calprotectin, CRP, and sedimentation rate were frequently reduced after STABILITY interviews, these data did not reach statistical significance. These preliminary findings suggest that STABILITY may be effective in maintaining low disease activity or remission in IBD patients. Full article
Back to TopTop